Literature DB >> 12067424

Total body phylloquinone and its turnover in human subjects at two levels of vitamin K intake.

Robert E Olson1, Jean Chao, Donna Graham, Margaret W Bates, Jessica H Lewis.   

Abstract

The aims of this study were to determine the total body phylloquinone and its metabolic turnover in human subjects using a tracer dose of [5-H3]phylloquinone containing 4 MBq/mmol. Seven subjects aged 22 to 49 years were given 0.3 microg isotopic phylloquinone intravenously on a control diet (75 microg phylloquinone/d) and blood, urine and faeces were sampled periodically for 6 d. Five of these subjects were studied a second time after 3-8 weeks on a low-vitamin K diet (8 microg/d). The changes in the radioactivity of plasma phylloquinone with time were analysed by the method of residuals and fitted to a curve composed of two exponential components. The size of the exchangeable body pool was calculated by isotope dilution. Plasma phylloquinone levels fell during vitamin K restriction but the vitamin K-dependent coagulation factors did not change. After injection the first exponential decay curve t1/2 was 1.0 (sd 0.47) h in the subjects on the control diet and 0.49 (sd 0.27) h after vitamin K restriction. On the control diet, the second exponential t1/2 was 27.6 (sd 124) h that did not change on the low-vitamin K diet ( (sd 13.5) h). These results indicate that the turnover time for phylloquinone in human subjects is about 1.5 d. Urinary excretion of 3H-metabolites ranged from 30 % of the administered dose on the control diet to 38 % on the restricted diet and had the same turnover rate as the second component of the plasma decay curves. The exchangeable body pool of phylloquinone declined from about 1.0 microg/kg before restriction to lower values after vitamin K restriction. The faecal excretion of phylloquinone and its metabolites fell from 32 % of the administered dose on the control diet to 13 % on the restricted diet.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067424     DOI: 10.1079/BJNBJN2002565

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  2 in total

1.  Role of prophylactic vitamin K in preventing antibiotic induced hypoprothrombinemia.

Authors:  Farookh Aziz; Prashant Patil
Journal:  Indian J Pediatr       Date:  2014-10-10       Impact factor: 1.967

Review 2.  Vitamin K--what, why, and when.

Authors:  E Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-03       Impact factor: 5.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.